the clinical applicability of the techniques. This article overviews the work on in-vitro culture of primordial follicle stages and on in-vitro maturation (IVM) of oocytes retrieved from antral follicle stages. Gametogenesis in the female has been comprehensively reviewed by Gosden (1995) and Driancourt et al. (1993) and is therefore briefly overviewed in this article.
The pool of primordial follicles represents the definitive number of female gametes for the entire 'reproductive' live span. Primordial follicles enter the growth phase progressively at a rate depending on the total number of units available in the intra-ovarian follicle pool at any time before menopause. The stimuli which govern the entrance of the primordial follicles into the growing set are as yet not clearly known and are probably both of a 'stimulatory' and of a 'relief from inhibition' order. These regulators trigger oocyte growth, granulosa cell proliferation and thecal cell differentiation. The earliest follicular growth phase, the preantral stage, is determined mainly by an increase in oocyte volume within the first few layers of granulosa cells that are formed. There is good evidence that this earliest growth of the follicle is under the control of the oocyte itself. Once oocytes have built up their cytoplasm (volume), follicular growth becomes concentrated on the somatic compartment. Granulosa cells remain proliferative and differentiate into two subpopulations: small, tightly connected granulosa cells surrounding the oocyte (cumulus cells) and larger, steroidproducing granulosa cells (the mural granulosa cell population). This differentiation into subpopulations coincides with antral cavity formation. At this developmental stage, the follicles become gonadotrophin-dependent as regards further development. In humans, the oocyte becomes meiotically competent (which means that, when released from the follicular environment, the meiotic block will be released) when a follicular diameter of ± 10 mm is reached.
The processes which lead to final oocyte maturation in-vivo are induced by the mid-cycle luteinizing hormone (LH) rise. During this maturation period, many intracellular changes take place to initiate the 'program' for early embryogenesis. Part of this maturation phase -nuclear maturation -can be morphologically evaluated by observation of the extrusion of the first polar body. During the breakdown of the germinal vesicle (GVBD), changes in the pattern of protein synthesis (Schultz et al., 1988) and intracellular cytoplasmic organelle rearrangements have been observed (Albertini, 1992) . The final maturation initiated by LH or by retrieval of the oocyte-cumulus complex (OCC) from the follicle is regulated predominantly by the second messenger cAMP which is provided from the granulosa and thecal parts of the follicle through gap junctions to the oocyte (Moor et al, 1980; Tornell and Hillensjo, 1993; Downs, 1995) . A decrease in intra-oocyte cAMP (mediated by phosphodiesterases) due to the breakage of the gap junctions between granulosa and oocyte results in the resumption of meiosis (Racowsky et al., 1989) .
Another proposed mechanism for the progression of meiosis is the generation of a positive signal originating in the somatic compartment of the follicle and transferred to the oocyte (Downs et al., 1988) . The release of Ca 2+ within 146 follicular cells and oocyte secondary to the LH trigger might be mediated by inositol 1,4,5-triphosphate (IP3) (Homa, 1995) . From in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) practice it has been observed that the yield of fully grown metaphase II oocytes is positively correlated to the size of the punctured follicles (Smitz et al, 1994) . As is known from studies in animal species, a clear relationship exists during oocyte growth between oocyte volume and the capacity to resume meiosis, to complete meiosis and to achieve competence for embryo development (Tsuji et al, 1985; Pavlok et al, 1992; Lonergan et al, 1994; Fair et al, 1995) .
In vivo, the prerequisites for a normal final oocyte maturation in humans are an oocyte which during its growth period has accumulated mRNA and proteins required for the autocatalytic amplification of m-phase promoting factor (MPF) to complete the G2-M transition and the generation of an adequate LH [or human chorionic gonadotrophin (HCG)] stimulus to drive the cascade of second messengers which regulate meiotic progression (Heikinheimo et al, 1995 (Heikinheimo et al, , 1996 .
The term 'in-vitro maturation of oocytes' refers to the in-vitro culture procedure which is used for very compacted OCC either retrieved from small (immature) diameter follicles and/or from larger follicles which have not been exposed to HCG. Although the larger part of the oocyte volume has already been acquired at the time that follicle cavitates, the oocyte has still to increase in volume and to undergo intracellular modifications (cytoplasmic maturation). Cytoplasmic maturation requires species-dependent protein synthesis at different steps of the meiotic process, which leads to the activation of MPF which in turn drives the G2-M progression (review from Masui, 1992) . This period of active protein syntheses also implies transcription in the cells which surround the oocyte and contribute to the final maturation of the female gamete. During this maturation period, relocation of cytoplasmic organelles and alterations to membrane transport systems take place (Kim et al, 1996; Ji et al, 1997) . Observations in the bovine model have shown that this cytoplasmic maturation is essential in giving the female gamete the competence to support fertilization and early embryonic development. Where this extended maturation period is not completed, early pregnancy failure will result (for review see Moor et al, 1998) .
The approach to culturing immature oocytes is completely different for very small (10-30 |im) oocytes from primordial and early preantral follicles and for almost fully grown oocytes (100-120 |im diameter) retrieved from antral follicle stages. For the sake of clarity, the two types of immature oocytes will be discussed separately. Until now, complete in-vitro development from a primordial follicle up to ovulation has been achieved only in mice (Eppig and O'Brien, 1996) .
Clinical rationale for developing early-stage follicle culture
There is a very strong demand from young female patients confronted with premature menopause (Turner syndrome, familial premature menopause) or definitive sterility (post-oncotherapy or post-surgery for severe endometriosis) to 147 establish techniques for retaining all future chances of procreation. Three very recent state of the art papers reviewed the cryopreservation of ovarian cortical tissue (Newton, 1998) , the new possibilities offered by autografting ovarian biopsies (Nugent et al, 1997) and the clinical management of patients who consider storing ovarian tissue to preserve their fertility (Donnez and Bassil, 1998) .
Only primordial and primary follicles constitute a realistic source for preservation and later use, i.e. those follicles surviving the cryopreservation process at a rate of 70-80% (Hovatta et al, 1996 (Hovatta et al, , 1997 Newton et al, 1996; Gook et al, 1999) . Primordial follicles are abundantly present in ovarian tissue. Early preantral follicles are unlikely to be an appropriate source for culture: of the total number of follicles in the ovarian cortex only ±8% are at the primary stage and 4% at the secondary stage (Lass et al., 1997) .
To establish the optimal culture conditions in an experimental scientific project, preantral and/or primordial follicles from consenting women with a normal menstrual cycle can be obtained by ovarian biopsy during a laparoscopic procedure. Another potential source of primordial follicles for research purposes is from second trimester abortions (Zhang et al., 1995) . Primordial follicles from prepuberal conditions might be regulated differently from adult follicles and their developmental competence might be reduced (Eppig and Schroeder, 1989; Gandolfi et al., 1998) . The oocytes within primordial follicles are still very small. The oocyte diameter in a primordial follicle is around 30 Jim diameter. The oocyte within a primordial follicle has to expand its volume > 300-fold before reaching the full potential for fertilization and development (120-130 \xm diameter). Once the primordial follicles come into the growing set in vivo, it takes ±85 days for them to reach the Graafian stage (Gougeon, 1986) . The exact control of the transition from the primordial to primary stage is as yet unknown.
Recent work on bovine and primate ovarian cortices suggests that serum factors in culture medium inhibit the growth of pre-granulosa cells which surround the immature oocyte (Wandji et al., 1996 (Wandji et al., , 1997 . As soon as fine ovarian tissue slices were incubated in serum-free medium, primordial follicles made the transition to the primary stage. Once the transition from primordial to primary follicles is accomplished, physical and biochemical conditions will have to be adapted to sustain follicular growth. Artificial matrices such as matrigel or collagen might be useful in supporting early follicle cohesion and oocyte growth (Hovatta et al, 1997) .
The induction of gonadotrophin dependency of early-stage follicles can depend on several factors, such as vasoactive intestinal polypeptide, norepinephrine, activin and transforming growth factor (3 2 (Kogawa et al, 1991; Dunkel et al, 1994; Li et al, 1995; Mayerhofer et al, 1997) . Besides provision of the essential growth promoters, the physical culture set-up must be such as to allow easy penetration of oxygen to the different follicle compartments.
The culture set-up for primordial human follicles will probably require a very dynamic system, providing several growth factors and physical stimuli for each of the different stages of follicular maturation. Today none of the research efforts for human primordial follicles have led to the demonstration of an increase in oocyte diameter in culture (personal unpublished observations, 1999 ). Most groups demonstrate the autonomous proliferation of granulosa cells, but the oocyte diameters stagnate and show signs of atresia after a few days of culture (Wandji et al, 1996 (Wandji et al, , 1997 Hovatta et al, 1997; Picton et al, 1999) .
In-vitro culture of preantral follicles Newton et al. (1999) attempted to culture fresh and frozen-thawed ovine ovarian tissue (OCC ranging from 100 to 240 pm in diameter). Complexes smaller than 190 Jim could not be maintained intact in serum-free culture. A three-dimensional structure could be maintained for OCC ^190 |im throughout culture (30 days), and 25% of the cultured units formed antral-like cavities and the P450 aromatase enzyme complex was kept functional. Over the 30 day culture period, oocytes grew from 78 ± 2 up to 131 ± 3 Jim. The in-vitro culture of oocytes from frozen follicles had an efficiency similar to that of fresh tissue.
Attempts to culture isolated preantral follicles from adult human ovaries have been made by Abir et al. (1997) , who grew preantral follicles of ^120 (im diameter for 4 weeks. However, the oocyte recovery rate from these cultures remained poor: only 20% of the follicles contained an oocyte at histological analysis. Experiments by Picton et al. (1999) demonstrated that in-vitro growth of human primordial follicles can be initiated when kept within ovarian stromal tissue, but intact follicle survival was limited (only 20%). Culture of follicles as isolated units can only survive in vitro and grow up to early antral stages when their diameter at start is >190 Jim.
Restoring follicular function by transplantation
Experiments have shown that in sheep and humans, primordial follicles in cortical tissue pieces can be successfully autografted (Gosden et al., 1994; Nugent et al., 1997) . Survival rates, as determined by the growth of cryopreserved human ovarian tissue pieces, ranged from 44 to 84% after xenografting into severe combined immune deficiency (SCID) mice (Newton et al., 1996) .
Growth and maturation of cryopreserved human primordial and primary follicles can be achieved by homologous transplantation of the frozen-thawed ovarian tissue (Nugent et al., 1997) . The survival of the follicles within the transplants was highly variable, which could be explained by the inadequate techniques used for taking the biopsy, processing the tissue pieces and the revascularization of the graft. A convenient site for transplantation, which has to be appropriate for revascularization and in addition provide easy accessibility to matured follicles, is under current investigation.
Clinical rationale for in-vitro oocyte maturation from antral follicle stages
Prior to oocyte retrieval for IVF, women are generally pretreated for some 2 weeks with GnRH analogues combined with human menopausal gonadotrophin (HMG) or purified gonadotrophin preparation. The cost of such drugs has increased substantially in recent years. Furthermore, the hormonal pretreatment period is often perceived as a long-lasting physical and psychological burden. Side-effects reported by ovulation induction treatment include weight gain, abdominal bloating, breast tenderness, nausea and mood swings. This treatment is also not without substantial risk (ovarian hyperstimulation syndrome, OHSS) and general discomfort. Especially in women belonging to the group of polycystic ovarian syndrome (PCOS) patients, the association of gonadotrophin releasing hormone (GnRH) analogues and follicle stimulating hormone (FSH) too often creates the clinical picture of moderate or severe clinical OHSS (Rizk and Smitz, 1992) . There is probably considerable under-reporting of the severe complications of ovulation induction, which include thromboembolism, paralysis and death.
The risk of severe complications may be avoided completely by applying more gentle ovarian stimulation and by omitting HCG injection.
Actual status of clinical practice for maturation of GV and metaphase I oocytes obtained after ovulation induction for IVF or ICSI
After conventional GnRH agonist and gonadotrophin ovulation induction treatment, the follicles with final diameters between 18 and 22 mm yield an average of 80% metaphase II oocytes. The remaining (20%) oocytes are categorized as being either at metaphase I or at the GV stage (Smitz et al., 1994) . As the aim of stimulation protocols is to provide a maximum of mature oocytes, the elaboration of an adequate specific oocyte maturation system for denuded metaphase I or GV oocytes might be useful. Especially poor responders and patients with an extremely unsynchronized cohort of follicles have a higher proportion of immature oocytes after stimulation. For this group the chance of pregnancy can be increased by the development of an oocyte maturation system. When cultured in a standard IVF medium (e.g. Earle's supplemented with human serum albumin), 50% of the metaphase I and 20% of the GV (from which the cumulus cells have been removed for nuclear maturation classification purposes) will reach metaphase II spontaneously within 24 h and possess the ability to fertilize and cleave (unpublished personal observations, 1994) . In a maturation medium conditioned by co-cultured cells the denuded immature gametes may lead to an enhanced nuclear maturation (Janssenswillen et al., 1995) . However, such co-cultured oocytes have not been evaluated for their fertilization or embryonic developmental potential.
Results after ICSI of immature (metaphase I) or in-vitro matured metaphase I oocytes reveal a reduced fertilization and cleavage potential and their developmental capacity has never been clearly demonstrated (Strassburger et al., 1999) .
Work on immature GV oocytes sporadically found during IVF and ICSI retrievals demonstrated that early preimplantation embryo development in regular IVF embryo culture media was defective after microinjection with donor spermatozoa of in-vitro matured, denuded oocytes (donated for research) (Nogueira 1998; Nogueira et al., 1998) . This poor developmental competence of the few immature oocytes, which are almost always retrieved together with a cohort of metaphase II oocytes, suggests that these oocytes had been exposed to an inadequate intrafollicular environment. Hence, it might not be justified to extrapolate the results from IVM of these sporadically found immature oocytes (post HCG injection) to oocytes which are retrieved on purpose from small diameter follicles (before the ovulatory HCG injection).
State of the art on culture of immature oocytes obtained from small antral follicles
In small mammals it has been shown that nuclear maturation (GVBD) can progress spontaneously by retrieving OCC from an 'arresting' follicular milieu (Pincus and Enzmann, 1935; Edwards, 1965) . It has also been shown that human oocyte diameter at collection determines its ability to resume meiosis and complete maturation. The following oocyte diameter cut-off points in relation to meiotic potential were deduced from data on human oocytes from unstimulated ovarian biopsy specimens: oocyte diameter ^105 |0,m: GV; oocyte diameter >105 (im: GVBD -» metaphase I; oocyte diameter >115 jim: GVBD -m etaphase II (Durinzi et al, 1995) . GV-stage oocytes can be aspirated by the ultrasound-guided transvaginal approach from proliferating antral follicular stages (2-17 mm diameter) even when no HCG has been administered (Trounson et al, 1994) . A reasonable number of OCC can be retrieved from small antral follicles with a modified follicle puncture: using a low-suction-pressure needle. From unstimulated or stimulated normo-ovulatory women or PCO patients 10 to 15 OCC were obtained (Cha et al, 1991; Trounson et al, 1994; Russell et al, 1997) . As reported in the literature, 55-70% of such aspirated OCC showed spontaneous nuclear maturation within 36-48 h and could be fertilized (rate: 30-45%). Although the first cleavage divisions from these fertilized oocytes were apparently morphologically normal (reported rates: 30-40%), clinical pregnancy rates were disappointingly low (Cha et al, 1991; Trounson et al, 1994; Barnes et al, 1995; Russell et al, 1997) .
A survey of the peer-reviewed literature over the last 10 years reveals that after IVM of immature oocytes, fewer than 6% children were born per embryo transfer procedure, despite the fact that reasonable fertilization and first cleavage division rates were reported (Cha et al, 1991; Trounson et al, 1994; Barnes et al, 1995; Russell et al, 1997) . Limited information could be drawn from the clinical studies on immature oocyte culture for the following reasons: (i) the various series were small, (ii) the culture material (OCC) was poorly characterized as to its follicular origin, (iii) the OCC were retrieved at different moments in the menstrual cycle and probably from follicles of different sizes, (iv) the patients were pretreated with a variety of stimulation drug regimens, (v) various basal culture media were used, which contained different hormones and/or growth factors, (vi) the concentration and nature of the protein source differed, and (vii) some researchers used co-culture on either granulosa or Vero cells.
Fortunately, previous publications on the culture of denuded or cumulusenclosed GV oocytes permitted us at least to extract some information on a number of essential points. There was no effect from the endocrine profile of the donor (ovulatory or anovulatory PCO) at the moment of oocyte retrieval on the outcome of immature oocyte culture (Trounson et al., 1994) .
The effect of the menstrual cycle phase at oocyte retrieval on oocyte maturation was studied by Whitacre et al. (1998) and oocytes collected in the follicular phase showed significantly more frequent GVBD than oocytes collected in the luteal phase. The moment of the cycle did not influence maturation of oocytes to metaphase II.
According to Trounson et al. (1994) co-culture of immature oocytes with somatic cells brought no additional benefit over the normal culture system. The zona hardening of the cultured OCC could be circumvented by using ICSI after first polar body extrusion (Barnes et al., 1995) . Oocytes retrieved after a brief FSH stimulation phase of 5 days had ah improved developmental competence (Schramm and Bavister, 1994; Wynn et al, 1998) .
More recent communications claim better results in terms of ongoing pregnancy rates. One abstract (Cha, 1997) reported pregnancy rates of 25% after IVM of OCC retrieved without stimulation from PCO patients. Cha's culture system, however, raised a major safety concern: the oocyte culture medium which was used contained 20% bovine serum and used a heterologous co-culture system. A recent abstract from Mikkelsen et al. (1998) emphasized the improved results by FSH stimulation where there was a delay between the last FSH injection and the oocyte retrieval. A similar improved in-vitro blastocyst development was first reported by Blondin and Sirard (1995) in the bovine model.
To the best of our knowledge, no systematic study has as yet been done to evaluate embryo quality and cytogenetics from in-vitro matured human oocytes. Assessment of the normality of these embryos is, however, crucial, as the GV oocytes are abnormally slow in their response to HCG or do not respond at all, and as the OCC might well originate from early atretic follicles. Before applying IVM techniques in clinical programmes it would be safer to analyse the embryos cytogenetically first.
Future improvements for retrieval of immature oocytes from antral follicles

The use of FSH increases the developmental capacity of immature (GV) oocytes
Several studies in different species have illustrated the beneficial effect of a growth-inducing pulse of gonadotrophins before immature OCC aspiration (Koering et al., 1994) . Priming with FSH followed by gonadotrophin withdrawal yielded a better oocyte recovery rate in humans (Wynn et al, 1997) . The FSH stimulates growth in a sensitive cohort of follicles and might enable a better discrimination of the growing pool from the atretic pool of follicles. Human GV oocytes exposed to gonadotrophins resumed GVBD 9 h earlier than controls, had an increased sperm-binding capacity and enhanced the migration dynamics of the male pronucleus (Van Blerkom et al, 1995; Cha and Chian, 1998) . Fertilized OCC yielded a higher blastocyst development rate in monkeys which had been primed with FSH (Schramm and Bavister, 1994) and an increased developmental competence of fertilized IVM oocytes in humans stimulated with FSH (Russell et al, 1997) .
Adaptations of the oocyte retrieval are helpful for improving immature oocyte recovery
A special needle with a reduced length, a short bevel and a more rigid structure was developed. A double lumen needle would be helpful in flushing, where OCC are not easily found. A HEPES-buffered pre-warmed solution supplemented with heparin should be used for replenishments. Reduction of the aspiration pressure used in the needle (reduction from 15 to 7.5 kPa) is essential. Immobilization of the ovary during puncture using holding instruments introduced through two 5 mm incisions in the lateral part of the lower abdomen is helpful (Trounson et al, 1994) .
In-vitro culture conditions for denuded oocytes and for OCC
A distinction should be made between culture conditions for the different kinds of collected materials.
Oocytes denuded in the gamete laboratory
When the 'feeder'-cell layers of the oocyte (granulosa cells) have been stripped off (for the purposes of ICSI), maturation factors can be provided to the oocyte only through the membrane (zona + oolemma). Theoretically, steroids could play a role in oocyte developmental capacity. Work from Tesarik and Mendoza (1997) demonstrated the positive effects of oestrogens and the negative impact of androgens on the development of calcium oscillations in oocytes. IVM allows steroid levels to adapt (androgen/oestrogen ratios) in such a way as to obtain a normal Ca 2+ response to spermatozoa at fertilization and normal development. Other growth factors [epidermal growth factor (EGF), insulin-like growth factor (IGF)-I and -II], for which the receptor system has been found on the oocyte could interact directly (Maruo et al, 1993; Wu et al, 1993; Zhou and Bondy, 1993; Bennett et al, 1996; Lighten et al, 1997) . The mRNA transcripts for activin receptor subtypes I and II have been demonstrated in human and bovine oocytes (Sidis et al, 1997; Yoshioka et al, 1998) . Additions of activin and inhibin to in-vitro culture medium of retrieved primate GV oocytes had a beneficial effect on oocyte maturation and on embryo developmental capacity (Alak et ah, 1996) . Very few reports based on human data are available on the potential use of culture media or growth factors for oocyte maturation and most often too few GV oocytes have been available for statistically significant comparisons. A controlled study showed that co-culture on Vero cells significantly improved meiotic maturation of cumulus-free GV oocytes (Janssenswillen et ah, 1995) . All in all, the absence of the surrounding somatic feeder cells compromises the possible interventions on oocyte maturation.
OCC from small antral follicles
Ultrasound follow-up of 2-\ mm large follicles revealed that before ovulation these follicles still have to undergo a growth period of 6-8 days. It therefore makes good sense that for each of the developmental stages at which immature oocytes (follicles) are retrieved a specific 'maturation' or 'culture system' will be necessary.
Because oocyte nuclear and cytoplasmic maturation, which can proceed as independent processes, need to be closely integrated to ensure developmental competence, the GV oocyte should ideally be kept meiotically arrested up to the moment that cytoplasmic maturation has been completed. This 'meiotic arrest in-vitro' might be attempted using drugs which interfere with cAMP metabolism (Downs, 1995) . Furthermore, the transzonal connections between granulosa cells and oocyte must be kept patent to enable transfer of important factors through gap junctions between the two cellular compartments. While the oocyte is meiotically arrested, an adequate culture medium composition should be defined in terms of growth factors and hormonal supplements to sustain completion of oocyte maturation.
The basic culture medium should support oocyte and cumulus cells so that they may interact as in vivo. In order to keep the paracrine action of the cells functional, a rational approach would involve culturing the OCC in microdroplets under a mineral oil layer (Cortvrindt et al., 1996; Wynn et ah, 1998) . This theoretical advantage should be further investigated by measuring nutrients and metabolic end products using micromethods. In a microdrop system the medium components critical to normal oocyte function could be depleted very rapidly, leading to serious deficits. The basic culture medium used should mimic follicular fluid from pre-ovulatory follicles as closely as possible.
The energy substrates should be in accordance with the specific needs of human oocytes. Human OCC were cultured into TCM 199, bicarbonate-buffered MEM with Earle's salts or Ham's F10 (Cha et ah, 1991; Mikkelsen et ah, 1998; Wynn et ah, 1998) .
A critical point in human embryo culture remains the choice of a protein supplement. For safety reasons it is advised not to supplement with serum sources from other species. In view of the potential danger of cross-contamination it would also be better not to use human serum or FF. Even when homologous serum is used, this source is of a very variable quality and precludes the definition of a defined culture condition. Prolonged culture in the absence of serum leads, however, to undesirable effects on the oocyte such as zona hardening or cortical granule release. Other substitutes might be found necessary to cover the 'serum functions': attachment factors, PVP or fetuin (Amsterdam and Rotmensch, 1987; Schroeder et al., 1990) . In the presence of serum, granulosa cells differentiate terminally, lose their ability to secrete oestrogens and change their shape (Erickson et al., 1979; Furman et al., 1986) . Furthermore use of serum in culture media introduces variability into the results and prohibits the study of the real needs of the oocyte during its maturation process.
Recent work from Campbell et al. (1996) proposed a species-specific serumfree long-term granulosa cell culture system based on the ratio of the two metabolic hormones insulin and IGF-I, the optimal plating density of the cells and the FSH concentration. Both insulin and IGF-I have to be added in physiological amounts depending on the stage of follicular development.
The presence of steroids in the culture medium might be important for the maintainance of intercellular contacts (oestrogens and progesterone) and for the oocyte's cytoplasmic maturation (Moor, 1978; Mattioli et al., 1988; Tesarik and Mendoza, 1997) . The actions of oestrogens and androgens on cytoplasmic maturation are mediated by factors located on the oocyte membrane and which do not involve the nuclear steroid receptor (Tesarik and Mendoza, 1995) . Oestrogens are, furthermore, involved in the induction of the synthesis of the male pronucleus growth factor (MPGF) in the oocytes (Moor et al., 1980; Fukushima and Fukui, 1985) . Oocytes cultured together with granulosa cells can be provided with oestrogen and progesterone through paracrine interaction.
Another important factor in a serum-free culture system includes transferrin: it has a chelator function and is a substrate for proteolytic enzymes released from dying cells. It is still questionable whether r-LH or r-HCG is useful in induction of the final maturation of in-vitro cultured OCC as the granulosa cells surrounding the oocyte might not express the LH receptor. The induction of the final maturation which stimulates the oocyte to accomplish nuclear maturation (a metaphase II oocyte) might necessitate involvement of EGF [EGF receptors are present on the oocyte, as was shown by Son et al. (1997) , or the genomic effects of a meiosis-activating sterol (Byskov et al., 1995) ]. The developmental potential of the oocyte is further regulated by a series of factors, amongst them: oocyte matrix metalloproteinases (MMP) and follicle cell tissue inhibitor of metalloproteinases (TIMP) (Funahashi et al., 1997) and the activin/inhibin system (Alak et al, 1996) .
Additional studies are warranted to study the influence of the several variables on nuclear and cytoplasmic maturation and to evaluate their stage-dependent effects. It is of crucial importance that the current type of analysis (assessment of meiotic progression, fertilization cleavage) be shifted to blastocyst formation and normal fetal development to term (Moor et al., 1998) . 
The technique of cytoplasmic transfer in immature oocytes
The experimental approach in monkeys showed that ooplasm from (donor) metaphase II oocytes which was injected in (acceptor) prophase I oocytes could successfully lead to full maturation and developmental competence (17% pregnancy rate) (Flood et ah, 1990) . More recently, 'ooplasmic transplantation' has been successfully used in humans suspected of having ooplasmic rather than nuclear anomalies leading to repeatedly poor embryo viability (Cohen et ai, 1998) . It is as yet too early to conclude whether this novel approach might present a valid solution to oocyte ageing. The safety of this procedure has still to be investigated before it can be proposed for routine clinical practice.
Final reflections
Storage of human ovarian cortical tissue has already become routinely applied in fertility centres where there is availability of a programmable freezing machine. However, few research groups have investigated culture conditions for oocyte and follicle maturation. Preliminary data from transplantation studies or longterm in-vitro culture of cryopreserved primordial follicles suggest that growth and maturation induction are technically possible but that prolonged research efforts will be required before acceptable survival rates are reached. Principally, research should explore two directions: (i) if there is no risk of cancer transmission, transplantation of ovarian tissue to heterotopic sites which should sustain follicular growth and offer easy accessibility for oocyte retrieval, and (ii) the design of a culture system for primordial and preantral follicles if there is any risk that cancer has spread into the ovary.
Due to the scarcity of good experimental material from human ovarian biopsies, advancement in the field of IVM of oocytes will benefit from the further unravelling of the fundamental biophysical and molecular mechanisms governing gametogenesis in large mammalian models. Much can be learned from experiences with animal models, but interspecies differences are important in the field of gametogenesis. It will therefore be impossible to simply extrapolate maturation protocols for human gametes even from experiments with large mammals. For each stage of follicular development there will be the need for an adapted culture environment as schematically shown in Figure 1 . The in-vitro maturation of OCC from antral follicles entered the phase of clinical applicability though results are still very poor. No straightforward protocol has as yet emerged from the several published papers because of a lack of prospective study designs. More systematic work in the large mammals permits the conclusion that age of the donor, pretreatment of the ovaries by FSH, follicle diameter at retrieval, presence of connecting cumulus cells, addition of specific growth factors (EGF, activin, growth hormone) to serum-free medium, and extension of the pre-maturation phase are determining factors the final outcome.
A prerequisite for improvement in this field includes a close interaction between reproductive clinicians and researchers in human and animal reproductive sciences. Safe in-vitro handling of gametes and ovarian tissue implies efficient logistics between the operating theatre and the tissue culture laboratory. The laboratory expertise has to cover a broad field: cell and tissue culture, microscopic techniques, cryobiology, fundamental endocrinology, molecular biology and molecular genetics.
